section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States
Dr. Rosenfield is a Master of SCAI and Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. Dr. Rosenfield is a master clinician and interventionalist has dedicated much of his career to educating fellows, residents, students, and colleagues. He received the distinguished Laennec award for his outstanding teaching and mentorship. As a researcher and clinical trialist, he designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He served as President of SCAI and was President of the MA ACC, serving on the Board of Governors of ACC. Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, founder of the National PERT Consortium.
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Access Vascular: Stock-privately held company (Ongoing); Althea Medical: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); AngioDynamics: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Auxetics: Scientific Advisory Board (Ongoing), Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing), Stock-privately held company (Ongoing); Bectin Dickinson: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); BioSense Webster, a J&J Company: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); CONTEGO MEDICAL: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing), Scientific Advisory Board (Ongoing); Endospan: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Getting-Atrium: Grant/Research Support (Ongoing); Imperative Care: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); InspireMD: Scientific Advisory Board (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Janacare: Stock-privately held company (Ongoing); Magneto: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); MedAlliance: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Neptune Medical: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing); Orchestra: Stock-publicly held company (excluding mutual/index funds) (Ongoing); PERT ConsortiumTM (Not For Profit 501(c) 3 Organization): Board Member (Ongoing); Philips: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sealonix: Stock-privately held company (Ongoing); Shockwave Medical, Inc.: Scientific Advisory Board (Terminated), Stock-publicly held company (excluding mutual/index funds) (Terminated); Skydance: Stock-privately held company (Ongoing); Summa Therapeutics: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Surmodics: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Terumo: Consultant (Terminated); Thrombolex: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular, Inc.: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Vasorum: Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); VuMedi: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing)
Monday, March 11, 2024
3:12 PM – 3:30 PM ET
Monday, March 11, 2024
2:30 PM – 2:40 PM ET